KIT and hematologic disorder: IL-6, in the cellular context of KIT mutations, not only induces DJ-1 expression in mast cells, it promotes secretion of ROS into the extracellular space, a feature that has been linked to some hematological malignancies and to cell transformation in general [1, 49, 50].